Wire · opportunities
Patients' Perspectives on Applications of AI and Personalized Medicine in Life-Threatening ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 26 August 2026 · Fusion42 review
A cross-sectional study of 470 European heart disease patients reveals broad acceptance of personalized risk prediction (PRP) and AI as decision support tools in implantable cardioverter-defibrillator (ICD) implantation, with a strong preference for transparency and patient involvement, while full delegation to AI is largely rejected.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
Heart disease care founders must prioritise patient-facing transparency and shared decision-making when embedding AI or personalized risk tools in treatment paths. Full AI control is off limits; focus on building systems that support, not replace, active patient participation.
◆ Coverage
1 source · 26 Aug 2026
◆ Related on Wire
◆ Topics